Novel [1,2,3]triazoles, [1,2,3]triazolo[4,5-d]Pyrimidines, and Some of Their Glycoside Derivatives: Synthesis and Molecular Modeling as Potential Apoptotic Antitumor Agents

References

• M. M. Alam, “1, 2, 3‐Triazole Hybrids as Anticancer Agents: A Review,” Archiv Der Pharmazie 355, no. 1 (2022): 2100158. doi:10.1002/ardp.202100158
   PubMed Web of Science ®Google Scholar
• M. A. Said, D. J. Khan, F. F. Al-Blewi, N. S. Al-Kaff, A. A. Ali, N. Rezki, M. R. Aouad, and M. Hagar, “New 1, 2, 3-Triazole Scaffold Schiff Bases as Potential anti-COVID-19: Design, Synthesis, DFT-Molecular Docking, and Cytotoxicity Aspects,” Vaccines 9, no. 9 (2021): 1012. doi:10.3390/vaccines9091012
   Web of Science ®Google Scholar
• H. Li, R. Aneja, and I. Chaiken, “Click Chemistry in Peptide-Based Drug Design,” Molecules (Basel, Switzerland) 18, no. 8 (2013): 9797–817. doi:10.3390/molecules18089797
   PubMed Web of Science ®Google Scholar
• Y. L. Angell, and K. Burgess, “Peptidomimetics via Copper-Catalyzed Azide–Alkyne Cycloadditions,” Chemical Society Reviews 36, no. 10 (2007): 1674–89. doi:10.1039/b701444a
   PubMed Web of Science ®Google Scholar
• S. G. Agalave, S. R. Maujan, and V. S. Pore, “Click Chemistry: 1, 2, 3‐Triazoles as Pharmacophores,” Chemistry, an Asian Journal 6, no. 10 (2011): 2696–718. doi:10.1002/asia.201100432
   PubMed Web of Science ®Google Scholar
• T. Muller, and S. Bräse, “Click Chemistry Finds Its Way into Covalent Porous Organic Materials,” Angewandte Chemie 50, no. 50 (2011): 11844–5. doi:10.1002/anie.201105707
   Google Scholar
• E. Bonandi, M. S. Christodoulou, G. Fumagalli, D. Perdicchia, G. Rastelli, and D. Passarella, “The 1, 2, 3-Triazole Ring as a Bioisostere in Medicinal Chemistry,” Drug Discovery Today 22, no. 10 (2017): 1572–81. doi:10.1016/j.drudis.2017.05.014
   PubMed Web of Science ®Google Scholar
• F. J. Smit, R. Seldon, J. Aucamp, A. Jordaan, D. F. Warner, and D. D. N’Da, “Synthesis and Antimycobacterial Activity of Disubstituted Benzyltriazoles,” Medicinal Chemistry Research 28, no. 12 (2019): 2279–93. doi:10.1007/s00044-019-02458-7
   Web of Science ®Google Scholar
• A. A. Ali, D. Gogoi, A. K. Chaliha, A. K. Buragohain, P. Trivedi, P. J. Saikia, P. S. Gehlot, A. Kumar, V. Chaturvedi, and D. Sarma, “Synthesis and Biological Evaluation of Novel 1, 2, 3-Triazole Derivatives as anti-Tubercular Agents,” Bioorganic & Medicinal Chemistry Letters 27, no. 16 (2017): 3698–703. doi:10.1016/j.bmcl.2017.07.008
   PubMed Web of Science ®Google Scholar
• S. Zhang, Z. Xu, C. Gao, Q.-C. Ren, L. Chang, Z.-S. Lv, and L.-S. Feng, “Triazole Derivatives and Their anti-Tubercular Activity,” European Journal of Medicinal Chemistry 138, no. 2017 (2017): 501–13. doi:10.1016/j.ejmech.2017.06.051
   PubMedGoogle Scholar
• K. Zhang, P. Wang, L.-N. Xuan, X.-Y. Fu, F. Jing, S. Li, Y.-M. Liu, and B.-Q. Chen, “Synthesis and Antitumor Activities of Novel Hybrid Molecules Containing 1, 3, 4-Oxadiazole and 1, 3, 4-Thiadiazole Bearing Schiff Base Moiety,” Bioorganic & Medicinal Chemistry Letters 24, no. 22 (2014): 5154–6. doi:10.1016/j.bmcl.2014.09.086
   PubMed Web of Science ®Google Scholar
• B. R. Nemallapudi, D. R. Guda, N. Ummadi, B. Avula, G. V. Zyryanov, C. S. Reddy, and S. Gundala, “New Methods for Synthesis of 1, 2, 3-Triazoles: A Review,” Polycyclic Aromatic Compounds 42, no. 6 (2020): 1–19. doi:10.1080/10406638.2020.1866038
   Web of Science ®Google Scholar
• Z. Xu, S.-J. Zhao, and Y. Liu, “1, 2, 3-Triazole-Containing Hybrids as Potential Anticancer Agents: Current Developments, Action Mechanisms and Structure-Activity Relationships,” European Journal of Medicinal Chemistry 183, no. 2019 (2019): 111700. doi:10.1016/j.ejmech.2019.111700
   PubMedGoogle Scholar
• I. Łakomska, M. Fandzloch, T. Muzioł, T. Lis, and J. Jezierska, “Synthesis, Characterization and Antitumor Properties of Two Highly Cytotoxic Ruthenium (III) Complexes with Bulky Triazolopyrimidine Ligands,” Dalton Transactions (Cambridge, England : 2003) 42, no. 17 (2013): 6219–26. doi:10.1039/c2dt32216a
   PubMed Web of Science ®Google Scholar
• Núbia Boechat, Luiz C. S. Pinheiro, Thiago S. Silva, Anna C. C. Aguiar, Alcione S. Carvalho, Monica M. Bastos, Carolina C. P. Costa, Sergio Pinheiro, Angelo C. Pinto, Jorge S. Mendonça, et al, “New Trifluoromethyl Triazolopyrimidines as anti-Plasmodium falciparum Agents,” Molecules (Basel, Switzerland) 17, no. 7 (2012): 8285–302. doi:10.3390/molecules17078285
   PubMed Web of Science ®Google Scholar
• H. N. Hafez, H.-A. Abbas, and A.-R. El-Gazzar, “Synthesis and Evaluation of Analgesic, anti-Inflammatory and Ulcerogenic Activities of Some Triazolo-and 2-Pyrazolyl-Pyrido [2, 3-d]-Pyrimidines,” Acta Pharmaceutica (Zagreb, Croatia) 58, no. 4 (2008): 359–78. doi:10.2478/v10007-008-0024-1
   PubMed Web of Science ®Google Scholar
• L.-H. Huang, Y.-F. Zheng, Y.-Z. Lu, C.-J. Song, Y.-G. Wang, B. Yu, and H.-M. Liu, “Synthesis and Biological Evaluation of Novel Steroidal [17, 16-d][1, 2, 4] Triazolo [1, 5-a] Pyrimidines,” Steroids 77, no. 6 (2012): 710–5. (2012) doi:10.1016/j.steroids.2012.03.002
   PubMed Web of Science ®Google Scholar
• Shuai Wang, Li-Jie Zhao, Yi-Chao Zheng, Dan-Dan Shen, Er-Fei Miao, Xue-Peng Qiao, Li-Juan Zhao, Ying Liu, Ruilei Huang, Bin Yu, et al, “Design, Synthesis and Biological Evaluation of [1, 2, 4] Triazolo [1, 5-a] Pyrimidines as Potent Lysine Specific Demethylase 1 (LSD1/KDM1A) Inhibitors,” European Journal of Medicinal Chemistry 125 (2017): 940–51. doi:10.1016/j.ejmech.2016.10.021
   PubMed Web of Science ®Google Scholar
• M. A. Radwan, F. M. Alminderej, H. E. Tolan, and H. M. Awad, “One-Pot Three-Component Synthesis of New Triazolopyrimidine Derivatives Bearing Indole Moiety as Antiproliferative Agents,” Journal of Applied Pharmaceutical Science 10, (2020): 12–22. doi:10.7324/japs.2020.10902
   Google Scholar
• A. M. Mohamed, M. Abdelwahab, D. H. Elnaggar, N. A. Abde lHafez, S. F. Mahmoud, M. El-Bayaa, D. S. El-Kady, M. M. Omran, and W. A. El-Sayed, “Synthesis, Cytotoxic Activity and Molecular Modelling of Novel 1, 2, 3] triazolo [4,5-d] Pyrimidine Compounds, Their Glycoside Derivatives and Acyclic Analogs." Egyptian Journal of Chemistry 65, no. 1 (2022): 645–656. doi:10.21608/ejchem.2021.84371.4127
   Web of Science ®Google Scholar
• T. A. Farghaly, I. M. Abbas, M. M. Abdalla, and R. O. Mahgoub, “Synthesis of New Pentaheterocyclic Ring Systems as anti-Androgene, anti-HCV and anti-H1N1 Agents,” Arkivoc 6 (2012): 57–70. doi:10.3998/ark.5550190.0013.606
   Web of Science ®Google Scholar
• T. A. Farghaly, and H. M. Hassaneen, “Synthesis of Pyrido [2, 3-d][1, 2, 4] Triazolo [4, 3-a] Pyrimidin-5-Ones as Potential Antimicrobial Agents,” Archives of Pharmacal Research 36, no. 5 (2013): 564–72. doi:10.1007/s12272-013-0045-2
   PubMed Web of Science ®Google Scholar
• S. M. Gomha, E. M. Abbas, and T. A. Farghaly, “Antimicrobial Activity of Novel Tetra‐and Penta‐Azaheterocyclic Ring Systems,” Journal of Heterocyclic Chemistry 54, no. 1 (2017): 610–7. doi:10.1002/jhet.2632
   Web of Science ®Google Scholar
• Abd. El-Meguid, E. A. G. O. Moustafa, H. M. Awad, E. R. Zaki, and E. S. Nossier, “Novel Benzothiazole Hybrids Targeting EGFR: Design, Synthesis, Biological Evaluation and Molecular Docking Studies,” Journal of Molecular Structure 1240, no. 2021 (2021): 130595. doi:10.1016/j.molstruc.2021.130595
   Google Scholar
• R. R. Khattab, A. A. Hassan, D. A A. Osman, F. M. Abdel-Megeid, H. M. Awad, E. S. Nossier, and W. A. El-Sayed, “Synthesis, Anticancer Activity and Molecular Docking of New Triazolo [4, 5-d] Pyrimidines Based Thienopyrimidine System and Their Derived N-Glycosides and Thioglycosides,” Nucleosides, Nucleotides & Nucleic Acids 40, no. 11 (2021): 1090–113. “No,” doi:10.1080/15257770.2021.1975297
   PubMed Web of Science ®Google Scholar
• R. R. Khattab, A. K. Alshamari, A. A. Hassan, H. H. Elganzory, W. A. El-Sayed, H. M. Awad, E. S. Nossier, and N. A. Hassan, “Click Chemistry Based Synthesis, Cytotoxic Activity and Molecular Docking of Novel Triazole-Thienopyrimidine Hybrid Glycosides Targeting EGFR,” Journal of Enzyme Inhibition and Medicinal Chemistry 36, no. 1 (2021): 504–16. “No,” doi:10.1080/14756366.2020.1871335
   PubMed Web of Science ®Google Scholar
• G. Elgemeie, M. Abou-Zeid, S. Alsaid, A. Hebishy, and H. Essa, “Novel Nucleoside Analogues: first Synthesis of Pyridine-4-Thioglycosides and Their Cytotoxic Evaluation,” Nucleosides, Nucleotides & Nucleic Acids 34, no. 10 (2015): 659–73. doi:10.1080/15257770.2015.1071843
   PubMed Web of Science ®Google Scholar
• G. H. Elgemeie, and D. H. El-Naggar, “Novel Dihydropyridine Thioglycosides and Their Corresponding Dehydrogenated Forms as Potent anti-Hepatocellular Carcinoma Agents,” Nucleosides, Nucleotides & Nucleic Acids 37, no. 4 (2018): 199–216. doi:10.1080/15257770.2018.1457161
   PubMed Web of Science ®Google Scholar
• F. M. Alminderej, H. H. Elganzory, M. N. El-Bayaa, H. M. Awad, and W. A. El-Sayed, “Synthesis and Cytotoxic Activity of New 1, 3, 4-Thiadiazole Thioglycosides and 1, 2, 3-Triazolyl-1, 3, 4-Thiadiazole N-Glycosides,” Molecules (Basel, Switzerland) 24, no. 20 (2019): 3738. doi:10.3390/molecules24203738
   PubMed Web of Science ®Google Scholar
• V. N. Toan, and N. D. Thanh, “Synthesis and Antiproliferative Activity of Hybrid Thiosemicarbazone Derivatives Bearing Coumarin and D-Galactose Moieties with EGFR Inhibitory Activity and Molecular Docking Study,” Medicinal Chemistry Research 30, no. 10 (2021): 1868–85. doi:10.1007/s00044-021-02773-y
   Web of Science ®Google Scholar
• D. H. Elnaggar, A. M. Mohamed, N. A. Abdel Hafez, M. E. Azab, M. E. Elasasy, H. M. Awad, T. A. Farghaly, and A. E.-G. E. Amr, “Antiproliferative Activity of Some Newly Synthesized Substituted Nicotinamides Candidates Using Pyridine-2 (1 H) Thione Derivatives as Synthon,” ACS Omega 7, no. 12 (2022): 10304–16. doi:10.1021/acsomega.1c06951
   PubMed Web of Science ®Google Scholar
• M. Elasasy, D. Elnaggar, N. Hafez, M. Azab, A. Amr, M. Omran, and A. Mohamed, “Synthesis and Antiproliferative Activity of Novel Hydrazono Thiazolidene and Thiazole Derivatives Bearing Rhodanine Moiety,” Russian Journal of General Chemistry 91, no. 5 (2021): 915–25. doi:10.1134/S1070363221050236
   Web of Science ®Google Scholar
• A. M. Mohamed, W. A. El-Sayed, A. A. Ibrahim, N. A. Abdel-Hafez, K. A. Ali, and S. F. Mohamed, “Recent Trends in the Chemistry of [1, 2, 4] Triazole [1, 5-a] Pyrimidines,” Organic Preparations and Procedures International 53, no. 3 (2021): 211–39. doi:10.1080/00304948.2020.1871310
   Web of Science ®Google Scholar
• H. S. Khalaf, H. E. Tolan, M. A. Radwan, A. M. Mohamed, H. M. Awad, and W. A. El-Sayed, “Design, Synthesis and Anticancer Activity of Novel Pyrimidine and Pyrimidine-Thiadiazole Hybrid Glycosides,” Nucleosides, Nucleotides & Nucleic Acids 39, no. 7 (2020): 1036–56. doi:10.1080/15257770.2020.1748649
   PubMed Web of Science ®Google Scholar
• A. Hassan, M. M. Ali, M. Diaa, M. O. Germoush, A. M. Mohamed, and W. El-Sayed, “Oxidative Stress of Some Triazolopyrimidine Derivatives and Their Nucleoside Analogues on Mcf-7 and A549 Cell Lines,” Egyptian Journal of Chemistry 63, no. 1 (2020): 247–53. doi:10.21608/ejchem.2019.18248.2136
   Web of Science ®Google Scholar
• B. G. Youssif, A. M. Mohamed, E. E. A. Osman, O. F. Abou-Ghadir, D. H. Elnaggar, M. H. Abdelrahman, L. Treamblu, and H. A. Gomaa, “5-Chlorobenzofuran-2-Carboxamides: From Allosteric CB1 Modulators to Potential Apoptotic Antitumor Agents,” European Journal of Medicinal Chemistry 177 (2019): 1–11. doi:10.1016/j.ejmech.2019.05.040
   PubMed Web of Science ®Google Scholar
• W. A. El-Sayed, A. M. Mohamed, H. S. Khalaf, D. S. EL-Kady, and M. Al-Manawaty, “Synthesis, Docking Studies and Anticancer Activity of New Substituted Pyrimidine and Triazolopyrimidine Glycosides,” Journal of Applied Pharmaceutical Science 7, no. 09 (2017): 001–11. doi:10.7324/japs.2017.70901
   Google Scholar
• A. Mohamed, N. Abdel-Hafez, A. Kassem, E. Abbas, and M. Mounier, “Synthesis of Some New Thiazole Derivatives and Their Cytotoxicity on Different Human Tumor Cell Lines,” Russian Journal of General Chemistry 87, no. 10 (2017): 2391–400. doi:10.1134/S1070363217100218
   Web of Science ®Google Scholar
• E. M. Flefel, W. A. El-Sayed, A. M. Mohamed, W. I. El-Sofany, and H. M. Awad, “Synthesis and Anticancer Activity of New 1-Thia-4-Azaspiro [4.5] Decane, Their Derived Thiazolopyrimidine and 1, 3, 4-Thiadiazole Thioglycosides,” Molecules (Basel, Switzerland) 22, no. 1 (2017): 170. doi:10.3390/molecules22010170
   PubMed Web of Science ®Google Scholar
• A. M. Mohamed, H. R. Al-Qalawi, W. A. El-Sayed, W. A. Arafa, M. S. Alhumaimess, and A. K. Hassan, “Anticancer Activity of Newly Synthesized Triazolopyrimidine Derivatives and Their Nucleoside Analogs,” Acta Poloniae Pharm. Drug Res 72 (2015): 307–18.
   PubMed Web of Science ®Google Scholar
• Jun-Jie Yang, Wei-Wei Yu, Long-Long Hu, Wen-Juan Liu, Xian-Hua Lin, Wei Wang, Qiansen Zhang, Pei-Li Wang, Shuo-Wen Tang, Xin Wang, et al, “Discovery and Characterization of 1 H-1, 2, 3-Triazole Derivatives as Novel Prostanoid EP4 Receptor Antagonists for Cancer Immunotherapy,” Journal of Medicinal Chemistry 63, no. 2 (2020): 569–90. (2019) doi:10.1021/acs.jmedchem.9b01269
   PubMed Web of Science ®Google Scholar
• Ahmed Kamal, Syed Mohammed Ali Hussaini, Shaikh Faazil, Y. Poornachandra, G. Narender Reddy, C. Ganesh Kumar, Vikrant Singh Rajput, Chitra Rani, Rashmi Sharma, Inshad Ali Khan, et al, “Anti-Tubercular Agents. Part 8: synthesis, Antibacterial and Antitubercular Activity of 5-Nitrofuran Based 1, 2, 3-Triazoles,” Bioorganic & Medicinal Chemistry Letters 23, no. 24 (2013): 6842–6. doi:10.1016/j.bmcl.2013.10.010
   PubMed Web of Science ®Google Scholar
• S. M. A. Hussaini, P. Yedla, K. S. Babu, T. B. Shaik, G. K. Chityal, and A. Kamal, “Synthesis and Biological Evaluation of 1, 2, 3‐Triazole Tethered Pyrazoline and Chalcone Derivatives,” Chemical Biology & Drug Design 88, no. 1 (2016): 97–109. doi:10.1111/cbdd.12738
   PubMed Web of Science ®Google Scholar
• K. Kiran, D. Ashok, B. A. Rao, M. Sarasija, and A. S. Rao, “Synthesis of Novel Pyrazoline Based Bis (1, 2, 3-Triazole) Scaffolds via Click Chemistry,” Journal of the Serbian Chemical Society 82, no. 3 (2017): 241–51. doi:10.2298/JSC160216076A
   Web of Science ®Google Scholar
• Giuliana Biagi, Anna Maria Bianucci, Alessio Coi, Barbara Costa, Laura Fabbrini, Irene Giorgi, Oreste Livi, Iolanda Micco, Federica Pacchini, Edoardo Santini, et al, “2, 9-Disubstituted-N6-(Arylcarbamoyl)-8-Azaadenines as New Selective A3 Adenosine Receptor Antagonists: Synthesis, Biochemical and Molecular Modelling Studies,” Bioorganic & Medicinal Chemistry 13, no. 15 (2005): 4679–93. doi:10.1016/j.bmc.2005.04.063
   PubMed Web of Science ®Google Scholar
• G. Biagi, . I. Giorgi, O. Livi, C. Manera, and V. Scartoni, “1, 2, 3-Triazolo [4, 5-e]-1, 2, 4-triazolo [3, 4-c] pyrimidines,” Journal of Heterocyclic Chemistry 36, no. 5 (1999): 1195–98., doi:10.1002/jhet.5570360514
   Google Scholar
• B. P. George, and H. Abrahamse, “Increased Oxidative Stress Induced by Rubus Bioactive Compounds Induce Apoptotic Cell Death in Human Breast Cancer Cells,” Oxidative Medicine and Cellular Longevity 2019 (2019): 6797921. doi:10.1155/2019/6797921
   PubMed Web of Science ®Google Scholar
• V. Krystof, and S. Uldrijan, “Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs,” Current Drug Targets 11, no. 3 (2010): 291–302. doi:10.2174/138945010790711950
   PubMed Web of Science ®Google Scholar
• J. Mason, A. Good, and E. Martin, “3-D Pharmacophores in Drug Discovery,” Current Pharmaceutical Design 7, no. 7 (2001): 567–97. doi:10.2174/1381612013397843
   PubMed Web of Science ®Google Scholar
• Molecular Operation Environment. MOE Molecular Operating Environment, Chemical Computing Group, Montreal, Quebec, Canada Chap. 2015. Retrieved from http://www.chemcomp.com.
   Google Scholar
• P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney, and M. R. Boyd, “New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening,” Journal of the National Cancer Institute 82, no. 13 (1990): 1107–12. “Jnci,” doi:10.1093/jnci/82.13.1107
   PubMed Web of Science ®Google Scholar
• K. M. Miranda, M. G. Espey, and D. A. Wink, “A Rapid, Simple Spectrophotometric Method for Simultaneous Detection of Nitrate and Nitrite,” Nitric Oxide : biology and Chemistry 5, no. 1 (2001): 62–71. doi:10.1006/niox.2000.0319
   PubMed Web of Science ®Google Scholar